Expression of hypoxia-inducible factor 1 alpha in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis

Virchows Archiv

Volumn 463, Issue 6, 2013, Pages 795-802

  Koperek, Oskar ^a   Akin, Erol ^a   Asari, Reza ^a   Niederle, Bruno ^a   Neuhold, Nikolaus ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Kaiser Franz Josef Spital   (Austria)

Author keywords

Desmoplasia; HIF 1 alpha; Hypoxia; Papillary thyroid carcinoma

Indexed keywords

B RAF KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TENASCIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CELLULAR PARAMETERS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DESMOPLASTIC STROMAL REACTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCHOOL CHILD; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; SCHOOL CHILD; STAINING; STROMA; THYROID CARCINOMA; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT; BIOSYNTHESIS; CARCINOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; THYROID TUMOR; TUMOR MICROENVIRONMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; TENASCIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT; YOUNG ADULT;

EID: 84890493623     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1484-3     Document Type: Article

References (46)

1. Beressi N, Campos JM, Beressi JP, Franc B, Niccoli-Sire P, Conte-Devolx B, Murat A, Caron P, Baldet L, Kraimps JL, Cohen R, Bigorgne JC, Chabre O, Lecomte P, Modigliani E (1998) Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases. Thyroid 8:1039-1044
2. Berra E, Milanini J, Richard DE, Le Gall M, Vinals F, Gothie E, Roux D, Pages G, Pouyssegur J (2000) Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 60:1171-1178
3. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G (2000) Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 60:4693-4696
4. Burrows N, Babur M, Resch J, Williams KJ, Brabant G (2011) Hypoxia-inducible factor in thyroid carcinoma. J Thyroid Res 2011:762905. doi: 10.4061/2011/762905
5. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T (1986) Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131-139
6. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH (2003) Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer 98:31-40
7. De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429-447
8. DeLellis R, Lloyd R, Heitz PU, Eng C (2004) Pathology and genetics of tumors of the endocrine organs. IARC, Lyon
9. Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10:9-22. doi: 10.1038/nrc2748
10. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659
11. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM (2006) Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 281:15215-15226. doi: 10.1074/jbc.M511408200
12. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440:1222-1226. doi: 10.1038/nature04695
13. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613
14. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205-38211. doi: 10.1074/jbc.M203781200
15. Grabellus F, Worm K, Schmid KW, Sheu SY (2012) The BRAF V600E mutation in papillary thyroid carcinoma is associated with glucose transporter 1 overexpression. Thyroid 22:377-382. doi: 10.1089/thy.2011.0401
16. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883-899. doi: 10.1016/j.cell.2010.01.025
17. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
18. Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 56:531-538
19. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139-1146, discussion 1146-1137
20. Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93:266-276
21. Kaserer K, Scheuba C, Neuhold N, Weinhausel A, Haas OA, Vierhapper H, Niederle B (2001) Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol 25:1245-1251
22. Kim WY, Kaelin WG (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22:4991-5004. doi: 10.1200/JCO.2004.05.061
23. Kitada T, Seki S, Sakaguchi H, Sawada T, Hirakawa K, Wakasa K (2003) Clinicopathological significance of hypoxia-inducible factor-1α expression in human pancreatic carcinoma. Histopathology 43:550-555. doi: 10.1111/j.1365-2559.2003.01733
24. Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55:1856-1862
25. Koperek O, Asari R, Niederle B, Kaserer K (2011) Desmoplastic stromal reaction in papillary thyroid microcarcinoma. Histopathology 58:919-924. doi: 10.1111/j.1365-2559.2011.03791.x
26. Koperek O, Bergner O, Pichlhofer B, Oberndorfer F, Hainfellner JA, Kaserer K, Horvat R, Harris AL, Niederle B, Birner P (2011) Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene. J Pathol 225:63-72. doi: 10.1002/path.2926
27. Koperek O, Kornauth C, Capper D, Berghoff AS, Asari R, Niederle B, von Deimling A, Birner P, Preusser M (2012) Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma. The American Journal of Surgical Pathology 36:844-850. doi: 10.1097/PAS.0b013e318246b527
28. Koperek O, Scheuba C, Cherenko M, Neuhold N, De Micco C, Schmid KW, Niederle B, Kaserer K (2008) Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology 52:623-630
29. Lim JH, Lee ES, You HJ, Lee JW, Park JW, Chun YS (2004) Ras-dependent induction of HIF-1alpha785 via the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion. Oncogene 23:9427-9431. doi: 10.1038/sj.onc.1208003
30. Liotta LA (1984) Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am J Pathol 117:339-348
31. Maschler S, Grunert S, Danielopol A, Beug H, Wirl G (2004) Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells. Oncogene 23:3622-3633
32. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A 94:8104-8109
33. Nikiforov YE (2011) Molecular analysis of thyroid tumors. Mod Pathol 24(Suppl 2):S34-43. doi: 10.1038/modpathol.2010.167
34. Pazaitou-Panayiotou K, Capezzone M, Pacini F (2007) Clinical features and therapeutic implication of papillary thyroid microcarcinoma. Thyroid 17:1085-1092
35. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS (2003) High frequency of BRAF mutations in nevi. Nature Genetics 33:19-20. doi: 10.1038/ng1054
36. Pugh CW, Gleadle J, Maxwell PH (2001) Hypoxia and oxidative stress in breast cancer. Hypoxia signalling pathways. Breast Cancer Res 3:313-317
37. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J (1999) p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274:32631-32637
38. Roti E, degli Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659-673
39. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G (2002) Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8:1831-1837
40. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, Haslett C (1999) Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 5:662-668
41. Shibaji T, Nagao M, Ikeda N, Kanehiro H, Hisanaga M, Ko S, Fukumoto A, Nakajima Y (2003) Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res 23:4721-4727
42. Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours. Wiley-Blackwell, New York
43. Sugino K, Ito K Jr, Ozaki O, Mimura T, Iwasaki H, Ito K (1998) Papillary microcarcinoma of the thyroid. J Endocrinol Invest 21:445-448
44. Sullivan R, Graham CH (2007) Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 26:319-331. doi: 10.1007/s10555-007-9062-2
45. Zalatnai A (2006) Molecular aspects of stromal-parenchymal interactions in malignant neoplasms. Curr Mol Med 6:685-693
46. Zerilli M, Zito G, Martorana A, Pitrone M, Cabibi D, Cappello F, Giordano C, Rodolico V (2010) BRAF(V600E) mutation influences hypoxia-inducible factor-1 alpha expression levels in papillary thyroid cancer. Modern Pathol 23:1052-1060. doi: 10.1038/modpathol.2010.86